BERKELEY, Calif., Feb. 8, 2011 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced that Steven B. Engle, Chairman and Chief Executive Officer, is scheduled to present a business overview and update at the BIO CEO and Investor Conference on Tuesday, February 15, 2011 at 9:30 a.m. Eastern time in New York City.
